Loading clinical trials...
Loading clinical trials...
Diagnostic, Transversal, Comparative, Not Randomized Trial for the Evaluation of Cystatin C as an Early Marker of Contrast-Medium Nephropathy in High-and-Intermedium-Risk Patients Undergoing to Cardiac Catheterization
Conditions
Locations
1
Mexico
Ignacio Chávez National Institute of Cardiology
Mexico City, Mexico City, Mexico
Start Date
December 1, 2006
Primary Completion Date
December 1, 2007
Completion Date
April 1, 2008
Last Updated
May 8, 2008
NCT04982419
NCT04334707
NCT01682590
NCT06926946
NCT05888376
NCT06516692
Lead Sponsor
National Heart Institute, Mexico
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions